Drug delivery, new therapies, AI, VR: Array of VCU inventors receive Commercialization Fund awards
A Virginia Commonwealth University pharmacy professor and his team have repurposed a long-approved drug that could soon be used to treat eye disorders such as diabetic retinopathy and age-related macular degeneration.
Richmond-Petersburg region, collaborating as the Alliance for Building Better Medicine, secures $111 million over three months for U.S. based manufacturing of essential medicine
Alliance for Building Better Medicine, a coalition of public and private sector stakeholders in the Richmond-Petersburg region, and Governor Glenn Youngkin yesterday honored National Essential Medicine Shortage Awareness Day by announcing $111 Million has been invested by federal, state, local, and private supporters over the past three months to accelerate the development of the advanced pharmaceutical and manufacturing cluster emerging in Central Virginia.
Richmond-Petersburg region is a winner of the national Build Back Better Regional Challenge
The U.S. Department of Commerce's Economic Development Administration (EDA) today announced that public and private sector stakeholders in the Richmond-Petersburg region, working together as the Alliance for Building Better Medicine, will receive $52,942,702 as a winner of the national Build Back Better Regional Challenge.
Richmond-Petersburg regional coalition, including VCU, awarded $53 million in Build Back Better Regional Challenge
Virginia Commonwealth University, will receive nearly $53 million as one of 21 winners of the national Build Back Better Regional Challenge.
Worth Longest research on more targeted aerosol drug delivery systems
As a Minnesota biotech company chases life-saving applications for their research, two VCU professors press forward on their work to use aerosols — tiny particles released into the airways — to deliver advanced drugs to those in need.
B. Frank Gupton, Ph.D., discusses a redesign of pharmaceutical manufacturing
Sharon Bowes, anchor and producer of NewsPoint360, interviews B. Frank Gupton, Ph.D., CEO of VCU Engineering’s Medicines for All Institute, co-founder of Phlow Corp. and the college’s Floyd D. Gottwald, Jr. Chair in pharmaceutical engineering.
VCU’s Medicines for All Institute drives down production costs of molnupiravir, the first investigational pill to treat COVID-19
The Medicines for All Institute (M4ALL) in the Virginia Commonwealth University College of Engineering has developed low-cost manufacturing processes for molnupiravir, the first investigational pill to treat COVID-19.
U.S. Rep. Abigail Spanberger announces pharmaceutical readiness legislation at VCU’s College of Engineering
U.S. Rep. Abigail Spanberger spoke at the VCU College of Engineering to announce the introduction of legislation to create a strategic national stockpile of key ingredients used in essential generic medicines and to incentivize domestic manufacturing of these ingredients.
National Institute for Pharmaceutical Technology and Education welcomes VCU Engineering as its 18th member
The National Institute for Pharmaceutical Technology and Education (NIPTE) is pleased to welcome Virginia Commonwealth University, through its College of Engineering, as its newest member.
VCU Engineering receives grants for job creation initiatives in pharmaceuticals, high-tech industries
To boost the availability of talent to fill the demand for high-paying, private sector, technical jobs in the greater Richmond region, Virginia Commonwealth University College of Engineering is leading two projects designed to support growth in the pharmaceutical industry and provide wide-ranging support across the expansive digital economy.
